Vincristine/volasertib polymersome injection enables high-efficiency synergistic treatment of acute lymphoblastic leukemia
Last Updated: Wednesday, May 28, 2025
In this report, a vincristine/volasertib polymersome (Ps-VCR/Vol) nanocombo is presented for synergistic high-efficacy ALL treatment. This nanocombo demonstrated strong synergy (3.3-6.8-fold) and enhanced anti-ALL activity in cells and mouse models, effectively inhibiting leukemia progression and prolonging survival without inducing toxicity.
Advertisement
News & Literature Highlights